Population Pharmacokinetics of Methylphenidate in Healthy Adults Emphasizing Novel and Known Effects of Several Carboxylesterase 1 (CES1) Variants

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Population Pharmacokinetics of Methylphenidate in Healthy Adults Emphasizing Novel and Known Effects of Several Carboxylesterase 1 (CES1) Variants. / Lyauk, Y K; Stage, C; Bergmann, T K; Ferrero, Laura; Bjerre, D; Thomsen, R; Dalhoff, K P; Rasmussen, H B; Jürgens, G.

I: Clinical and Translational Science, Bind 9, Nr. 6, 12.2016, s. 337–345.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Lyauk, YK, Stage, C, Bergmann, TK, Ferrero, L, Bjerre, D, Thomsen, R, Dalhoff, KP, Rasmussen, HB & Jürgens, G 2016, 'Population Pharmacokinetics of Methylphenidate in Healthy Adults Emphasizing Novel and Known Effects of Several Carboxylesterase 1 (CES1) Variants', Clinical and Translational Science, bind 9, nr. 6, s. 337–345. https://doi.org/10.1111/cts.12423

APA

Lyauk, Y. K., Stage, C., Bergmann, T. K., Ferrero, L., Bjerre, D., Thomsen, R., Dalhoff, K. P., Rasmussen, H. B., & Jürgens, G. (2016). Population Pharmacokinetics of Methylphenidate in Healthy Adults Emphasizing Novel and Known Effects of Several Carboxylesterase 1 (CES1) Variants. Clinical and Translational Science, 9(6), 337–345. https://doi.org/10.1111/cts.12423

Vancouver

Lyauk YK, Stage C, Bergmann TK, Ferrero L, Bjerre D, Thomsen R o.a. Population Pharmacokinetics of Methylphenidate in Healthy Adults Emphasizing Novel and Known Effects of Several Carboxylesterase 1 (CES1) Variants. Clinical and Translational Science. 2016 dec.;9(6):337–345. https://doi.org/10.1111/cts.12423

Author

Lyauk, Y K ; Stage, C ; Bergmann, T K ; Ferrero, Laura ; Bjerre, D ; Thomsen, R ; Dalhoff, K P ; Rasmussen, H B ; Jürgens, G. / Population Pharmacokinetics of Methylphenidate in Healthy Adults Emphasizing Novel and Known Effects of Several Carboxylesterase 1 (CES1) Variants. I: Clinical and Translational Science. 2016 ; Bind 9, Nr. 6. s. 337–345.

Bibtex

@article{805afba4543849a79aad82d955bbe254,
title = "Population Pharmacokinetics of Methylphenidate in Healthy Adults Emphasizing Novel and Known Effects of Several Carboxylesterase 1 (CES1) Variants",
abstract = "The aim of this study was to identify demographic and genetic factors that significantly affect methylphenidate (MPH) pharmacokinetics (PK), and may help explain interindividual variability and further increase the safety of MPH. d-MPH plasma concentrations, demographic covariates, and carboxylesterase 1 (CES1) genotypes were gathered from 122 healthy adults and analyzed using nonlinear mixed effects modeling. The structural model that best described the data was a two-compartment disposition model with absorption transit compartments. Novel effects of rs115629050 and CES1 diplotypes, as well as previously reported effects of rs71647871 and body weight, were included in the final model. Assessment of the independent and combined effect of CES1 covariates identified several specific risk factors that may result in severely increased d-MPH plasma exposure.",
author = "Lyauk, {Y K} and C Stage and Bergmann, {T K} and Laura Ferrero and D Bjerre and R Thomsen and Dalhoff, {K P} and Rasmussen, {H B} and G J{\"u}rgens",
note = "{\textcopyright} 2016 The Authors. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics.",
year = "2016",
month = dec,
doi = "10.1111/cts.12423",
language = "English",
volume = "9",
pages = "337–345",
journal = "Clinical and Translational Science (Print)",
issn = "1752-8054",
publisher = "Wiley-Blackwell",
number = "6",

}

RIS

TY - JOUR

T1 - Population Pharmacokinetics of Methylphenidate in Healthy Adults Emphasizing Novel and Known Effects of Several Carboxylesterase 1 (CES1) Variants

AU - Lyauk, Y K

AU - Stage, C

AU - Bergmann, T K

AU - Ferrero, Laura

AU - Bjerre, D

AU - Thomsen, R

AU - Dalhoff, K P

AU - Rasmussen, H B

AU - Jürgens, G

N1 - © 2016 The Authors. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics.

PY - 2016/12

Y1 - 2016/12

N2 - The aim of this study was to identify demographic and genetic factors that significantly affect methylphenidate (MPH) pharmacokinetics (PK), and may help explain interindividual variability and further increase the safety of MPH. d-MPH plasma concentrations, demographic covariates, and carboxylesterase 1 (CES1) genotypes were gathered from 122 healthy adults and analyzed using nonlinear mixed effects modeling. The structural model that best described the data was a two-compartment disposition model with absorption transit compartments. Novel effects of rs115629050 and CES1 diplotypes, as well as previously reported effects of rs71647871 and body weight, were included in the final model. Assessment of the independent and combined effect of CES1 covariates identified several specific risk factors that may result in severely increased d-MPH plasma exposure.

AB - The aim of this study was to identify demographic and genetic factors that significantly affect methylphenidate (MPH) pharmacokinetics (PK), and may help explain interindividual variability and further increase the safety of MPH. d-MPH plasma concentrations, demographic covariates, and carboxylesterase 1 (CES1) genotypes were gathered from 122 healthy adults and analyzed using nonlinear mixed effects modeling. The structural model that best described the data was a two-compartment disposition model with absorption transit compartments. Novel effects of rs115629050 and CES1 diplotypes, as well as previously reported effects of rs71647871 and body weight, were included in the final model. Assessment of the independent and combined effect of CES1 covariates identified several specific risk factors that may result in severely increased d-MPH plasma exposure.

U2 - 10.1111/cts.12423

DO - 10.1111/cts.12423

M3 - Journal article

C2 - 27754602

VL - 9

SP - 337

EP - 345

JO - Clinical and Translational Science (Print)

JF - Clinical and Translational Science (Print)

SN - 1752-8054

IS - 6

ER -

ID: 168932555